| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.26 | 7e-06 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0001 |